bf/NASDAQ:BMRN_icon.png

NASDAQ:BMRN

BioMarin

  • Stock

62.71

−1.54%

4.41

USD last updated 14/08 01:46:41

Last Close

58.30

13/08 21:56

Market Cap

15.63B

Beta: 0.38

Volume Today

1.38M

Avg: 1.37M

PE Ratio

112.42

PFCF: 528.69

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase fo...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.4-0.20.20.40.60.82018-10-252020-04-292022-02-232023-07-312024-10-29

    Revenue (Estimate*)

    1B2B3B4B2018-10-252020-04-292022-02-232023-07-312024-10-29

    *Estimate based on analyst consensus